New AI helps lower cost of drug discoveryAustralian researchers have created a new drug discovery AI tool for decoding protein-molecule interactions without the need for rendering costly 3D structures.
Their drug discovery model called PSICHIC (PhySIcoCHemICal)…
What You Should Know:
– Vultr, the world’s largest, privately-held cloud computing platform, today announced that Athos Therapeutics, Inc. (“Athos”), a clinical-stage biotechnology company, has chosen Vultr Cloud GPU to run its AI model training,…
Continue Reading
Google Research and Google DeepMind recently released a paper announcing the creation of a new LLM for drug discovery and therapeutic development dubbed Tx-LLM, fine-tuned from PaLM-2.Tx-LLM utilizes the tech giant’s PaLM-2, its generative…
Continue Reading
What You Should Know:
– Helix, a leader in population genomics, is launching new datasets designed to empower life science companies in developing precision medicine therapies.
– These comprehensive datasets, built through collaborations with various health…
Continue Reading
News
Researchers at George Mason University’s public health school create MeAgainMeds.com, a free AI-powered website that uses self-reported patient history and data that was extracted from 3.6 million patient records to help patients and clinicians…
Continue Reading
What You Should Know:
– Weave Bio, an AI-native life sciences platform company, announced today the public release of its flagship offering, AutoIND, and $10 million in seed funding co-led by Innovation Endeavors and Magnetic…
Continue Reading
What You Should Know:
– Sanofi, a global pharmaceutical leader, Formation Bio, an AI-powered drug developer, and OpenAI, a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration. The first-of-its-kind partnership…
Continue Reading
What You Should Know:
– Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
– The investment aims…
Continue Reading
What You Should Know:
– Harnessing the power of AI for healthcare just got simpler. NVIDIA announced the integration of NVIDIA NIM, a collection of cloud-native AI microservices, with Amazon Web Services (AWS).
– The strategic…
Continue Reading
What You Should Know:
– BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug…
Continue Reading
